CHPN - Certified Hospice and Palliative Nurse Pain Management Strategies Questions and Answers — Questions and Answers
Question 1: A hospice patient with metastatic bone cancer reports a new type of pain described as 'burning' and 'tingling' in their lower extremities, which is not well-controlled by their current regimen of long-acting morphine. Which of the following interventions would be most appropriate for the CHPN to anticipate?
- Requesting an order to increase the dose of the long-acting morphine.
- Administering a non-steroidal anti-inflammatory drug (NSAID) for breakthrough pain.
- Initiating a non-pharmacological intervention such as deep breathing exercises.
- Collaborating with the provider to add an adjuvant analgesic like gabapentin. (Correct answer)
Correct answer: Collaborating with the provider to add an adjuvant analgesic like gabapentin.
The patient's description of 'burning' and 'tingling' pain is characteristic of neuropathic pain. While opioids are effective for nociceptive pain, neuropathic pain often requires the addition of an adjuvant analgesic. Gabapentin, an anticonvulsant, is a first-line treatment for neuropathic pain and is commonly used in conjunction with opioids to improve pain control.
Question 2: A patient is being managed on Step 3 of the WHO analgesic ladder with a strong opioid for severe cancer pain. According to the foundational principles of the WHO ladder, which of the following is a key concept in managing this patient's pain effectively?
- Administering analgesics only when the patient reports pain.
- Using the parenteral route exclusively for strong opioids.
- Giving analgesics 'by the clock' to maintain a stable level of pain control. (Correct answer)
- Discontinuing all non-opioid analgesics when a strong opioid is started.
Correct answer: Giving analgesics 'by the clock' to maintain a stable level of pain control.
A core principle of the WHO analgesic ladder is to administer analgesics 'by the clock,' meaning at regular, scheduled intervals, rather than waiting for the patient to experience pain. This proactive approach prevents breakthrough pain and maintains a more consistent state of comfort. The oral route is preferred whenever possible, and non-opioids or other adjuvants may be continued.
Question 3: A CHPN is caring for a patient who has been on a stable dose of oral morphine for several weeks. The patient now presents with increasing confusion, myoclonus (muscle twitching), and tactile hallucinations. The nurse recognizes these as potential signs of which opioid-related complication?
- Opioid-induced constipation
- Anaphylactic reaction
- Opioid-induced neurotoxicity (Correct answer)
- Serotonin syndrome
Correct answer: Opioid-induced neurotoxicity
The cluster of symptoms including cognitive changes (confusion, hallucinations) and neuromuscular excitation (myoclonus) are classic signs of opioid-induced neurotoxicity (OIN). This can occur with the accumulation of opioid metabolites. Management often involves hydration, dose reduction, or rotating to a different opioid like fentanyl or methadone.
Question 4: Which of the following non-pharmacological interventions is a manipulative and body-based practice that a CHPN can employ to manage a patient's pain and provide comfort?
- Guided imagery
- Music therapy
- Gentle massage (Correct answer)
- Aromatherapy
Correct answer: Gentle massage
Gentle massage is a manipulative, body-based therapy that can help ease muscle tension, improve circulation, and promote relaxation, thereby reducing pain perception. While guided imagery, music therapy, and aromatherapy are valuable non-pharmacological interventions, they are classified differently (e.g., mind-body or sensory therapies) and do not primarily involve physical manipulation of the body's tissues.
Question 5: A hospice nurse is initiating opioid therapy for a patient with severe, constant pain. To proactively manage the most common and persistent side effect of opioids, which of the following actions should the nurse prioritize?
- Administering an antiemetic with the first dose.
- Instructing the patient to report any signs of drowsiness.
- Initiating a scheduled bowel regimen with a stimulant laxative. (Correct answer)
- Monitoring for respiratory depression every hour.
Correct answer: Initiating a scheduled bowel regimen with a stimulant laxative.
Constipation is the most common and persistent side effect of opioid therapy, as tolerance does not typically develop. Therefore, a proactive, scheduled bowel regimen (e.g., a stimulant laxative like senna with or without a stool softener) should be initiated simultaneously with the opioid to prevent opioid-induced constipation (OIC). While nausea and sedation can occur, tolerance often develops within a few days.
Question 6: A patient with end-stage COPD is experiencing significant pain and dyspnea. The care team decides to initiate a low-dose opioid. The patient's family expresses fear that using morphine will hasten the patient's death through respiratory depression. What is the CHPN's most appropriate response?
- "We can use a non-opioid alternative like acetaminophen to avoid that risk."
- "The principle of double effect ethically allows us to use opioids for comfort, even if it shortens life."
- "That's a valid concern, but addiction is not a primary worry at this stage of life."
- "When used in low, carefully managed doses for symptom control, the risk of significant respiratory depression is very low and studies show it is safe." (Correct answer)
Correct answer: "When used in low, carefully managed doses for symptom control, the risk of significant respiratory depression is very low and studies show it is safe."
This response directly addresses the family's fear with factual reassurance. Clinical evidence shows that when opioids are used in appropriate, titrated doses to relieve pain and dyspnea at the end of life, clinically significant respiratory depression is rare. While the principle of double effect is a relevant ethical concept, it may not be the most therapeutic initial response. Shifting the focus to addiction is not responsive to the family's stated fear of respiratory depression.
A hospice patient with metastatic bone cancer reports a new type of pain described as 'burning' and 'tingling' in their lower extremities, which is not well-controlled by their current regimen of long-acting morphine.
Which of the following interventions would be most appropriate for the CHPN to anticipate?